|Articles|May 5, 2021

Lessons Learned in Pathology and Oncology From the COVID-19 Pandemic

Targeted Oncology is proud to partner with the American Society of Clinical Pathology to present a 1-hour webinar with an expert panel, moderated by Dan Milner, MD, MSc, MBA.


Related to this article

FDA Removes PCNSL Limitation From Liso-Cel Label
The November 2026 prescribing information removes the limitation that previously excluded patients with primary or secondary central nervous system lymphoma from the therapy’s large B-cell lymphoma indications.